Sign inJoin waitlistJoin the waitlist

Sumati Gupta

Associate Professor · Huntsman Cancer Institute & Hospital

Credentials: · · · ·

History

Huntsman Cancer Institute & Hospital · Univ of Utah Sch of Med
Present
Univ of Utah Sch of Med
Present

Geriatric Medicine
Baylor College of Medicine
2000–2001
Internal Medicine
Nassau University Medical Center
1997–2000
King Edward Memorial hospital and Seth G.S Medical College, Mumbai, India
1993–1997
Medical Oncology
University of Utah School of Medicine
1993–1996

Research

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and…
The Lancet Oncology · 2018 · 221 citations
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Cancer Discovery · 2018 · 215 citations
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Journal of the National Comprehensive Cancer Network · 2021 · 189 citations

Neeraj Agarwal
28 papers
Umang Swami
22 papers
BM
Benjamin Maughan
17 papers · 1 as a fellow
Petros Grivas
12 papers
Sumanta Pal
10 papers
VT
Vinay Thomas
10 papers · 8 as a fellow
Georges Gebrael
8 papers · 8 as a resident
Haoran Li
8 papers · 7 as a fellow
Nicolas Sayegh
8 papers · 6 as a resident
Nishita Tripathi
8 papers · 6 as a resident
UV
Ulka Vaishampayan
8 papers
Alejandro Sanchez
7 papers

Grants

Targeting ARID1A Mutated Urothelial Carcinoma
Department of Veterans Affairs · I01
Contact PI · Va Salt Lake City Healthcare System
2023–2027

Clinical trials

Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
Principal investigator · Active not recruiting · Phase 1
University of Utah
2022–2028
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2021–2033
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2018–2031